128 related articles for article (PubMed ID: 28850312)
21. Pazopanib-Associated Transient Ischemic Attack.
Revuelta-Herrero JL; Escudero-Vilaplana V; Álvarez-Álvarez R; Sanjurjo-Sáez M
Am J Ther; 2018; 25(3):e393-e394. PubMed ID: 29424756
[No Abstract] [Full Text] [Related]
22. A multiple retroperitoneal paraganglioma presenting as a cardiogenic shock in a 14-year-old male.
Acosta-Mérida MA; Silvestre-Rodríguez J; Hernández-Ramírez JM; Godoy C; Marchena-Gómez J
Cir Esp (Engl Ed); 2020; 98(6):362-364. PubMed ID: 31753286
[No Abstract] [Full Text] [Related]
23. Outcomes of unselected patients with metastatic clear-cell renal cell carcinoma treated with first-line pazopanib therapy followed by vascular endothelial growth factor receptor tyrosine kinase inhibitors or mammalian target of rapamycin inhibitors: a single institution experience.
Matrana MR; Bathala T; Campbell MT; Duran C; Shetty A; Teegavarapu P; Kalra S; Xiao L; Atkinson B; Corn P; Jonasch E; Tannir NM
BJU Int; 2016 Aug; 118(2):264-71. PubMed ID: 26573089
[TBL] [Abstract][Full Text] [Related]
24. Rare case of a dopamine-secreting para-aortic paraganglioma.
Best O; Lendzion R; Chung H; Lam V
ANZ J Surg; 2020 Mar; 90(3):E59-E60. PubMed ID: 31081228
[No Abstract] [Full Text] [Related]
25. The cytology of bronchial brushings from a malignant paraganglioma metastasizing to the lung.
Stephen MR; Moffat D; Burnett RA
Cytopathology; 1999 Jun; 10(3):211-5. PubMed ID: 10390071
[No Abstract] [Full Text] [Related]
26. The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.
Mori Y; Kinoshita S; Kanamori T; Kataoka H; Joh T; Iida S; Takemoto M; Kondo M; Kuroda J; Komatsu H
Intern Med; 2018 Sep; 57(18):2753-2757. PubMed ID: 29780156
[TBL] [Abstract][Full Text] [Related]
27. [Effective treatment of metastatic rhabdomyosarcoma with pazopanib].
Hashimoto A; Takada K; Takimoto R; Horiguchi H; Sato T; Iyama S; Murase K; Ono K; Tatekoshi A; Hayashi T; Miyanishi K; Sato Y; Kobune M; Hirayama Y; Kitamura H; Nakanishi K; Masumori N; Hasegawa T; Kato J
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1041-4. PubMed ID: 25132042
[TBL] [Abstract][Full Text] [Related]
28. Primary retroperitoneal neoplasms: CT findings in 90 cases with clinical and pathologic correlation.
Lane RH; Stephens DH; Reiman HM
AJR Am J Roentgenol; 1989 Jan; 152(1):83-9. PubMed ID: 2535771
[No Abstract] [Full Text] [Related]
29. Angiosarcoma of the scalp successfully treated with pazopanib.
Tomita H; Koike Y; Asai M; Ogawa F; Abe K; Tanioka M; Utani A
J Am Acad Dermatol; 2014 Jan; 70(1):e19-21. PubMed ID: 24176520
[No Abstract] [Full Text] [Related]
30. Ultrasonic and computed tomographic appearances of paraganglioma simulating pancreatic mass.
Malthouse SR; Robinson L; Rankin SC
Clin Radiol; 1992 Apr; 45(4):271-2. PubMed ID: 1395386
[TBL] [Abstract][Full Text] [Related]
31. [Non-secreting, extra-adrenal retroperitoneal paragangliomas].
Madrigal Rubiales B; Vara Castrodeza A; Fresno Forcelledo M; Ablanedo Ablanedo P
Arch Esp Urol; 2002 Jun; 55(5):543-7. PubMed ID: 12174422
[TBL] [Abstract][Full Text] [Related]
32. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.
Semenisty V; Naroditsky I; Keidar Z; Bar-Sela G
BMC Cancer; 2015 May; 15():402. PubMed ID: 25967676
[TBL] [Abstract][Full Text] [Related]
33. Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.
Pinciroli P; Won H; Iyer G; Canevari S; Colecchia M; Giannatempo P; Raggi D; Pierotti MA; De Braud FG; Solit DB; Rosenberg JE; Berger MF; Necchi A
Clin Genitourin Cancer; 2016 Feb; 14(1):e81-90. PubMed ID: 26371421
[No Abstract] [Full Text] [Related]
34. Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Sun M; Trinh QD; Perrotte P; Karakiewicz PI
Eur Urol; 2014 May; 65(5):1014-5. PubMed ID: 24646500
[No Abstract] [Full Text] [Related]
35. Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Ouzaid I; Rini B
Eur Urol; 2014 Mar; 65(3):667-8. PubMed ID: 24484761
[No Abstract] [Full Text] [Related]
36. Outcomes of patients with metastatic renal cell carcinoma treated with pazopanib in daily clinical practice: a single institution experience.
Ricotta R; Di Bella S
Tumori; 2014; 100(3):e87-91. PubMed ID: 25076258
[TBL] [Abstract][Full Text] [Related]
37. A rarely seen case among retroperitoneal mass lesions: paraganglioma.
Yildirim Ç; Yüksel ÖH; Ürkmez A; Özbay N; Verit A
Georgian Med News; 2014 Oct; (235):41-4. PubMed ID: 25416215
[TBL] [Abstract][Full Text] [Related]
38. [Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma].
Büchler T; Finek J; Hájek J; Kocák I; Kubácková K; Lakomý R; Melichar B; Petruzelka L; Poprach A; Siffnerová M; Tomásek J; Vyzula R; Zemanová M;
Klin Onkol; 2013; 26(1):55-7. PubMed ID: 23607143
[No Abstract] [Full Text] [Related]
39. [Recurrence of Well Differentiated Intrascrotal Liposarcoma in Retroperitoneum Five Years after Resection : A Case Report].
Yoshinaga M; Sekii Y; Nakazawa S; Nakagawa M; Kishikawa H; Nishimura K
Hinyokika Kiyo; 2017 Jan; 63(1):25-29. PubMed ID: 28245542
[TBL] [Abstract][Full Text] [Related]
40. Tumour-bowel fistula as a possible complication of pazopanib therapy in retroperitoneal leiomyosarcoma.
Pereira ROL; Patel PR; Guru PK; Sanghavi DK
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31712231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
